Ignite Creation Date:
2025-12-17 @ 8:39 PM
Ignite Modification Date:
2025-12-23 @ 9:02 PM
Study NCT ID:
NCT00736489
Status:
None
Last Update Posted:
2014-05-19 00:00:00
First Post:
2008-08-15 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Single-dose Crossover Study to Investigate Pharmacodynamics of AZD3199
Sponsor:
None
Organization:
Study Overview
Official Title:
A Phase II, Double-blind, Placebo-controlled, Randomised, 6-way Cross-over, Single-dose Study to Investigate the Local and Systemic Effects of 3 Doses of Inhaled AZD3199 (a β2-agonist) Compared to Formoterol in Asthmatic Patients
Status:
None
Status Verified Date:
2014-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the pharmacodynamics of single doses of AZD3199 in asthmatic patients.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: